FDA approval for RAPIBLYK® (landiolol) for use in pediatric patients with SVT provides first therapeutic option for these ...

AOP Health US, LLC today announced that the U.S. Food and Drug Administration (FDA) has approved RAPIBLYK (landiolol) for use in pediatric patients (from birth to This press release features ...

The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...

View Adagio Medical Holdings, Inc ADGM stock quote prices, financial information, real-time forecasts, and company news from CNN.

Cryopreserver Vitrafy has reported promising initial results from a follow-up blood platelet freezing trial with the US ...

Miller School of Medicine could one day change the way people with atrial fibrillation are treated. Researchers at UM ...

For patients with atrial fibrillation, the use of oral anticoagulant therapy to prevent stroke is limited by the risk of bleeding. Left atrial appendage closure is considered for patients who are ...

New research from a multi-institutional team, published in Nature Cardiovascular Research, reveals that heart failure and atrial fibrillation share underlying genetic and molecular mechanisms, ...

Stroke and systemic embolism occur at a low rate after catheter-based atrial ablation and may result in substantial sequelae or even death in certain cases.

Researchers quantify the risk for heart failure among people who screen positive for atrial fibrillation and suggest ECG ...

Atrial fibrillation treatment with device closure matched anticoagulants and reduced bleeding risk. Discover what this means for AF care.